These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 283639)

  • 1. [Experience in acceleration and blastic crisis in chronic myelocytic leukemia].
    Pralle H; Löffler H
    Verh Dtsch Ges Inn Med; 1978; (84):204-6. PubMed ID: 283639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia].
    Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F
    Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase.
    Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimism in leukemia treatment.
    Can Med Assoc J; 1973 Apr; 108(7):821. PubMed ID: 4513359
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial of hydroxyurea in chronic myelocytic leukemia.
    Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R
    Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
    Schwarzmeier JD; Haas O; Paietta E; Fischer P
    Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of chronic myelocytic leukemia treated with splenectomy in the early stage of the blastic crisis (author's transl)].
    Endo K; Saeki S; Sato I; Suzuki T; Tajima G; Horino Y; Mikami M; Onodera S; Yoshinaga K
    Rinsho Ketsueki; 1979 Mar; 20(3):273-9. PubMed ID: 286083
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
    Kiss A; Jakó J; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
    Winton EF; Miller D; Vogler WR
    Cancer Treat Rep; 1981; 65(5-6):389-92. PubMed ID: 6165470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Splenectomy in myelocytic leukemia].
    Petukhov VI
    Ter Arkh; 1980; 52(10):135-40. PubMed ID: 7003790
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74.
    Baccarani M; Ruggero D; Tura S
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):278-88. PubMed ID: 367386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies in blastic crisis of chronic myelocytic leukemia.
    Goh K
    Arch Intern Med; 1967 Sep; 120(3):315-20. PubMed ID: 5231842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences in the treatment of chronic myeloid leukemia].
    Pensabene A; Panzacchi G; Cipriani D
    Haematologica; 1971; 56(3):163-8. PubMed ID: 5003589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical picture of blastic crisis in chronic myelocytic leukemia].
    Donner L; Klener P; Roth Z
    Vnitr Lek; 1977 Sep; 23(10):937-45. PubMed ID: 270251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Terminal DNA nucleotidyltransferase in blastic crisis in myelocytic leukemia].
    Rudzka E; Bartnikowa W; Hołowiecki J; Japa J; Schneiberg K
    Acta Haematol Pol; 1981; 12(2):97-101. PubMed ID: 6946663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
    Leong SS; Sokal JE; Gomez GA; Horoszewicz JS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
    Klener P; Donner L
    Ther Hung; 1981; 29(1):38-41. PubMed ID: 6964902
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
    Schwartz JH; Cannellos GP
    Blood; 1975 Jul; 46(1):11-6. PubMed ID: 1055610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.